Lower counts of astroglia and activated microglia in patients with Alzheimer's disease with regular use of non-steroidal anti-inflammatory drugs

Journal of Alzheimer's Disease

Volumn 2, Issue 1, 2000, Pages 37-46

  Alafuzoff, Irina ^a,b   Overmyer, Margit ^a   Helisalmi, Seppo ^b   Soininen, Hilkka ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; IBUPROFEN; KETOPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ALZHEIMER DISEASE; ARTICLE; BRAIN DEGENERATION; BRAIN TISSUE; CELL ACTIVATION; CELL COUNT; DISEASE COURSE; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; HUMAN; MACROGLIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0034081386     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2000-2105     Document Type: Article

References (27)

1. Alafuzoff I, Helisalmi S, Mannermaa A, Riekkinen Sr P, Soininen H, b-amyloid load is not influenced by the severity of cardiovascular disease in aged and demented patients, Stroke 30 (1999) 613-618.
2. Arnold SE, Franz BR, Trojanowski JQ, Moberg PJ, Gur RE, Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia, Acta Neuropathol 91 (1996) 269-277.
3. Barger SW, Harmon AD, Microglial activation by Alzheimer precursor protein and modulation by Apolipoprotein E, Nature 16 (1997) 114-127.
4. Breitner JCS, The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease, Annu Rev. Med 47 (1996) 401-411.
5. Carpenter AF, Carpenter PW, Markesbery WR, Morphometric analysis of microglia in Alzheimer's disease, J Neuropath Exp Neurol 52 (1993) 601-608.
6. Diedrich JF, Minnigan H, Carp RI, Whitaker JN, Race R, Frey W, Haase AT, Neuropathological changes with increased expression of apolipo-protein E and cathepsin D in astrocytes, J Virol 65 (1991) 4759-4768.
7. DiPatre PL, Gelman BB, Microglial cell activation in aging and Alzheimer disease: Partial linkage with neurofibrillary tangle burden in the hippocampus, J Neuropathol Exp Neurol 2 (1997) 143-149.
8. Egensperger R, Kösel S, Ulrich von E, Gracber MB, Microglia activation in Alzheimer's disease: association with ApoE genotype, Brain Pathol 8 (1998) 439-447.
9. Gehrmann J, Matsumoto Y, Kreutzberg GW, Microglia: intrinsic immunoeffector cell of the brain, Brain Res Rev 20 (1995) 269-287.
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM, Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the department of health and Human Task Force of Alzheimer's Disease, Neurology 34 (1984) 939-944.
11. Kimelberg HK, Norenberg MB, Astrocytes, Sci Am 260 (1989) 44-52.
12. Krazpulski M, Soininen H, Riekkinen P Sr, Alafuzoff I, Pitfalls in the quantitative estimation of b-amyloid immunoreactivity in human brain tissue, Histochem Cell Biol 110 (1998) 439-445.
13. Mackenzie IR, Munoz DG, Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging, Neurology 50 (1998) 986-990.
14. Mattiace LA, Davies P, Dickson DW, Detection of HLA DR on microglia in the human brain is a function of both clinical and technical factors, Am J Pathol 136 (1990) 1101-14.
15. Meda L, Cassatella MA, Szendrei GI, Otvos Jr L, Baron P, Villalba M, Ferrari D, Rossi F, Activation of microglial cells by b-amyloid protein and interferon-g, Nature 374 (1995) 647-650.
16. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Highes JP, vanBelle G , Berg L, The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 (1991) 479-486.
17. Mölsä PK, Sako E, Paljärvi L, Rinne JO, Rinne UK, Alzheimer's disease: neuropathological correlation of cognitive and motor disorders, Acta Neurol Scand 75 (1987) 376-384.
18. Nagy ZS, Esiri MM, Jobst KA, Johnston C, Litchfield S, Sim E, Smith AD, Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease, Neurosci 69 (1995) 757-761.
19. Netland EE, Newton JL, Majocha RE, Tate BA, Indomethacin reverses the microglial response to amyloid beta-protein, Neurobiol-Aging 19 (1998) 201-204.
20. Oropeza RL, Wekerle H, Werb Z, Expression of apolipoprotein E by mouse astrocytes and its modulation by interferon gamma, Brain Res 410 (1987) 45-51.
21. Overmyer M, Helisalmi S, Soininen H, Laakso M, Riekkinen PSr, Alafuzoff I, Astrogliosis and the ApoE genotype. Dement, Geriatr Cogn Disord. 10 (1999) 252-257.
22. Overmyer M, Helisalmi S, Soininen H, Laakso M, Riekkinen PSr, Alafuzoff I, Reactive microglia in aging and dementia. An immunohistochemical study of postmortem human brain tissue, Acta Neuropathol 97 (1999) 383-392.
23. Rogers J, Kirby LC, Hempelman SR, Berry DL, McGeer PL, Kaszniak AW; Zalinski J, Cofield M, Mansukhani L, Willson P, Kogan F, Clinical trial of indomethacin in Alzheimer's disease. Neurology 43 (1993) 1609-1611.
24. Saitoh T, Kang D, Mallory M, DeTeresa R, Masliah E, Glial cells in Alzheimer's disease: preferential effect of ApoE risk on scattered microglia. Gerontology 43 (1997) 109-118.
25. Sasaki A, Nakazato Y, The identity of cells expressing MHC class II antigen in normal and pathologic human brain, Neuropathol Appl Neurobiol 18 (1992) 13-26.
26. Soininen H, Riekkinen Sr PJ, Apolipoprotein E, memory and Alzheimer's disease, Trends Neurosci 19 (1996) 224-228.
27. Tsukamoto K, Watanabe T, Matsushima T, Kinoshita M, Kato H, Hashimoto Y, Kurokawa K, Teramoto T, Determination by PCR-RFLP of apoE genotype in a Japanese population, J Lab Clin Med 121 (1993) 598-602.